Pharmacy key for Saxenda
February 1, 2016
PHARMACIES across Australia
are being invited to take part in a
comprehensive patient weight loss
support program launched on Fri by
Novo Nordisk.
The program is based around
Saxenda (liraglutide) which is a
once-daily glucagon-like peptide-1
(GLP-1) analogue self-injection used
for appetite regulation (PD Fri).
Participating pharmacies will be
promoted as “Saxenda Network
Pharmacies,” complementing
initiatives to highlight the new
obesity option to prescribers.
Saxenda comes in a prefilled pen,
and patients in the program will be
provided needles for the system
at no charge when redeemed at
Saxenda Network Pharmacies.
Available on private prescription,
doctors will identify suitable
patients and advise them of the
private prescription cost of the item
which is about $387 per month.
The first month’s supply from
the GP is free, and participating
pharmacies may also be able to
claim a professional service fee
of $22.36 by agreeing to deliver
additional care to the patient.
The Saxenda Pharmacy Program
is a free information and support
service for patients who have been
prescribed the medication by their
doctor and enrolled in the scheme.
It aims to ensure better
compliance to the medicine, along
with timely access to information
and additional value in the form of
the free needles.
Several banner groups have
already signed up for the program
including Terry White Chemists and
Blooms The Chemist.
The program has been developed
with the assistance of Kos Sclavos
from Sinapse, who said it would
“help pharmacists better engage
with patients on their weight
management journey.”
Pharmacies wanting to register for
the program can call 1800 668 626.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 16
